言語を選択

BTN3A1

BTN3A1 詳細

英語名	Butyrophilin subfamily 3 member A1	市販薬剤の数	0
治験薬の数	1	ターゲットの別称	BTF5，BTN3A1，CD_antigen，BTN3.1，BT3.1，DJ45P21.3 (Butyrophilin， Subfamily 3， Member A1)，Butyrophilin， Subfamily 3， Member A1，CD277 Antigen
研究＆開発段階	Phase 2 Clinical

英語名	Butyrophilin subfamily 3 member A1
ターゲットの別称	BTF5，BTN3A1，CD_antigen，BTN3.1，BT3.1，DJ45P21.3 (Butyrophilin， Subfamily 3， Member A1)，Butyrophilin， Subfamily 3， Member A1，CD277 Antigen
市販薬剤の数	0
治験薬の数	1
研究＆開発段階	Phase 2 Clinical

BTN3A1 製品リスト

属性
Protein (3)
製品ライブラリ
オンライン (3)
種
Human (3)
タグ
Fc Tag (1)His Tag & Avi Tag (1)His Tag (1)
マーカー
Unconjugated (2)Biotin-labeled (1)

製品番号	種	発現システム	製品説明
HOT BT1-H5255	Human	HEK293	Human BTN3A1 / CD277 Protein, Fc Tag (MALS verified)
HOT BT1-H52H4	Human	HEK293	Human BTN3A1 / CD277 Protein, His Tag, active dimer, low endotoxin (MALS verified)
HOT BT1-H82E4	Human	HEK293	Biotinylated Human BTN3A1 / CD277 Protein, His,Avitag™

総数量3

BTN3A1バックグランド

Butyrophilin subfamily 3 member A1 (BTN3A1) is also known as CD277 and BTF5, which belongs to the immunoglobulin superfamily and contains one B30.2/SPRY domain and two Ig-like V-type (immunoglobulin-like) domains. BTN3A1 plays a role in T-cell activation and in the adaptive immune response. Also, BTN3A1 regulates the proliferation of activated T-cells and the release of cytokines and IFNG by activated T-cells. Furthermore, BTN3A1 mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.